 Richard Davidson
Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lenses, Intraocular | 4 | 2022 | 43 | 1.200 |
Why?
| | Ophthalmology | 3 | 2022 | 82 | 1.040 |
Why?
| | Cataract | 4 | 2022 | 208 | 0.950 |
Why?
| | Phacoemulsification | 3 | 2021 | 115 | 0.910 |
Why?
| | Myopia | 2 | 2021 | 47 | 0.850 |
Why?
| | Conjunctiva | 3 | 2017 | 51 | 0.740 |
Why?
| | Refractive Surgical Procedures | 1 | 2021 | 5 | 0.720 |
Why?
| | Cataract Extraction | 4 | 2022 | 96 | 0.610 |
Why?
| | Presbyopia | 1 | 2016 | 14 | 0.510 |
Why?
| | Refractive Errors | 3 | 2020 | 18 | 0.440 |
Why?
| | Keratomileusis, Laser In Situ | 2 | 2020 | 22 | 0.370 |
Why?
| | Eye Burns | 1 | 2010 | 12 | 0.350 |
Why?
| | Lens Implantation, Intraocular | 3 | 2021 | 59 | 0.340 |
Why?
| | Sclera | 1 | 2010 | 36 | 0.340 |
Why?
| | Amnion | 1 | 2010 | 27 | 0.340 |
Why?
| | Refraction, Ocular | 2 | 2021 | 36 | 0.340 |
Why?
| | Burns, Chemical | 1 | 2010 | 29 | 0.340 |
Why?
| | Eyelids | 1 | 2010 | 34 | 0.340 |
Why?
| | Corneal Injuries | 1 | 2010 | 50 | 0.320 |
Why?
| | Scleritis | 1 | 2007 | 19 | 0.270 |
Why?
| | Surgical Flaps | 1 | 2007 | 135 | 0.240 |
Why?
| | Glucocorticoids | 2 | 2010 | 573 | 0.210 |
Why?
| | Keratitis | 1 | 2003 | 14 | 0.210 |
Why?
| | Corneal Stroma | 1 | 2003 | 17 | 0.210 |
Why?
| | Descemet Stripping Endothelial Keratoplasty | 1 | 2022 | 7 | 0.200 |
Why?
| | Endothelium, Corneal | 1 | 2022 | 16 | 0.200 |
Why?
| | Intraocular Pressure | 2 | 2016 | 297 | 0.200 |
Why?
| | Anesthesia, Local | 1 | 2021 | 15 | 0.190 |
Why?
| | Anesthetics, Local | 1 | 2021 | 74 | 0.180 |
Why?
| | Aberrometry | 1 | 2021 | 9 | 0.180 |
Why?
| | Optics and Photonics | 1 | 2021 | 40 | 0.180 |
Why?
| | Astigmatism | 1 | 2020 | 10 | 0.170 |
Why?
| | Biometry | 1 | 2021 | 69 | 0.170 |
Why?
| | Dexamethasone | 1 | 2003 | 345 | 0.170 |
Why?
| | Lens Capsule, Crystalline | 1 | 2020 | 11 | 0.170 |
Why?
| | Cornea | 1 | 2021 | 127 | 0.170 |
Why?
| | Glaucoma | 1 | 2003 | 219 | 0.160 |
Why?
| | Lasers, Excimer | 1 | 2020 | 29 | 0.160 |
Why?
| | Pain, Postoperative | 1 | 2021 | 222 | 0.160 |
Why?
| | Intraoperative Complications | 1 | 2020 | 129 | 0.160 |
Why?
| | Pain Management | 1 | 2021 | 321 | 0.150 |
Why?
| | Visual Acuity | 1 | 2020 | 322 | 0.140 |
Why?
| | Pterygium | 1 | 2017 | 4 | 0.140 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2016 | 17 | 0.140 |
Why?
| | Accommodation, Ocular | 1 | 2016 | 10 | 0.130 |
Why?
| | Burnout, Professional | 1 | 2022 | 407 | 0.130 |
Why?
| | Pain | 1 | 2021 | 751 | 0.120 |
Why?
| | Humans | 17 | 2022 | 128499 | 0.120 |
Why?
| | Postoperative Complications | 3 | 2017 | 2462 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2021 | 974 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2021 | 889 | 0.110 |
Why?
| | Physicians | 1 | 2022 | 863 | 0.110 |
Why?
| | Sulfonamides | 1 | 2016 | 495 | 0.100 |
Why?
| | Bone Lengthening | 1 | 2011 | 6 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2021 | 14472 | 0.090 |
Why?
| | Bone Malalignment | 1 | 2011 | 12 | 0.090 |
Why?
| | Dry Eye Syndromes | 1 | 2011 | 53 | 0.090 |
Why?
| | Ointments | 1 | 2010 | 24 | 0.090 |
Why?
| | Femur | 1 | 2011 | 248 | 0.080 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1201 | 0.070 |
Why?
| | Anti-Bacterial Agents | 2 | 2010 | 1705 | 0.070 |
Why?
| | Suture Techniques | 1 | 2007 | 118 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2020 | 4874 | 0.060 |
Why?
| | Optic Atrophy | 1 | 2003 | 10 | 0.050 |
Why?
| | Descemet Membrane | 1 | 2022 | 5 | 0.050 |
Why?
| | Tobramycin | 1 | 2003 | 51 | 0.050 |
Why?
| | Tonometry, Ocular | 1 | 2003 | 88 | 0.050 |
Why?
| | Visual Fields | 1 | 2003 | 87 | 0.050 |
Why?
| | Tissue and Organ Harvesting | 1 | 2022 | 72 | 0.050 |
Why?
| | Cell Count | 1 | 2022 | 310 | 0.050 |
Why?
| | Microscopy | 1 | 2022 | 140 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5045 | 0.040 |
Why?
| | Rupture | 1 | 2020 | 89 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 1016 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 388 | 0.040 |
Why?
| | Reward | 1 | 2021 | 237 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2007 | 2719 | 0.040 |
Why?
| | Postoperative Period | 1 | 2020 | 324 | 0.040 |
Why?
| | Arthritis, Rheumatoid | 1 | 2007 | 1088 | 0.040 |
Why?
| | Prosthesis Design | 1 | 2020 | 304 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 569 | 0.040 |
Why?
| | Female | 5 | 2022 | 68268 | 0.030 |
Why?
| | Physician-Patient Relations | 1 | 2021 | 530 | 0.030 |
Why?
| | Male | 5 | 2020 | 63045 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1004 | 0.030 |
Why?
| | External Fixators | 1 | 2011 | 15 | 0.020 |
Why?
| | Ophthalmoscopy | 1 | 2011 | 35 | 0.020 |
Why?
| | Ophthalmic Solutions | 1 | 2011 | 73 | 0.020 |
Why?
| | Adult | 2 | 2020 | 35302 | 0.020 |
Why?
| | Middle Aged | 2 | 2020 | 30923 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5371 | 0.020 |
Why?
| | Radiography | 1 | 2011 | 795 | 0.020 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 335 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7057 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 684 | 0.020 |
Why?
| | United States | 1 | 2022 | 13840 | 0.010 |
Why?
| | Aged | 1 | 2020 | 21976 | 0.010 |
Why?
| | Risk Factors | 1 | 2011 | 9737 | 0.010 |
Why?
| | Child, Preschool | 1 | 2011 | 10487 | 0.010 |
Why?
| | Young Adult | 1 | 2011 | 12349 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 20304 | 0.010 |
Why?
| | Child | 1 | 2011 | 20805 | 0.010 |
Why?
|
|
Davidson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|